Swissmedic has signed a memorandum of understanding with the Federal Institute for Drugs and Medical Devices in Germany. This is the third agreement that the Swiss regulatory agency has entered into in Europe in the push for cross-border regulatory networking. The MoU is meant to promote mutual understanding of regulatory rules, frameworks and processes between the agencies.

Related Summaries